Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: J Neurol. 2018 Jul 30;265(10):2267–2276. doi: 10.1007/s00415-018-8981-x

Fig. 2.

Fig. 2.

Perfusion maps, vasoreactivity, and gait speed for two participants with T2DM.

Perfusion maps for two representative participants with T2DM using a 3T, 3-dimensional CASL MRI show (a) a participant with higher global vasoreactivity at baseline and has faster gait speed during DTW at the two-year follow-up, and (B) a participant with lower global vasoreactivity and has slower gait speed during DTW at the two-year follow-up. The gait speed difference shows the percent changes in gait speed between the two-year follow-up and baseline. *unit–mL/100g/min/mmHg.